The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 10, 2015
Filed:
Aug. 14, 2012
Applicants:
Brad O. Buckman, Oakland, CA (US);
John B. Nicholas, Redwood City, CA (US);
Kumaraswamy Emayan, Berkeley, CA (US);
Scott D. Seiwert, Half Moon Bay, CA (US);
Inventors:
Brad O. Buckman, Oakland, CA (US);
John B. Nicholas, Redwood City, CA (US);
Kumaraswamy Emayan, Berkeley, CA (US);
Scott D. Seiwert, Half Moon Bay, CA (US);
Assignee:
InterMune, Inc., Brisbane, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 495/04 (2006.01); C07D 307/66 (2006.01); C07D 213/75 (2006.01); C07D 413/10 (2006.01); C07D 417/12 (2006.01); C07D 231/40 (2006.01); C07D 401/10 (2006.01); C07D 405/12 (2006.01); C07D 413/04 (2006.01); C07D 249/06 (2006.01); C07D 257/06 (2006.01); C07D 401/04 (2006.01); A61K 31/381 (2006.01); A61K 31/426 (2006.01); C07D 333/20 (2006.01); A61K 31/4192 (2006.01); A61K 31/4427 (2006.01); A61K 31/415 (2006.01); C07D 275/03 (2006.01); C07D 261/14 (2006.01); A61K 31/4155 (2006.01); C07D 471/04 (2006.01); C07H 15/26 (2006.01); C07D 491/04 (2006.01); A61K 31/425 (2006.01); A61K 31/421 (2006.01); C07D 491/048 (2006.01); C07D 277/46 (2006.01); C07D 263/48 (2006.01); C07D 207/34 (2006.01); A61K 31/42 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); C07D 401/04 (2013.01); A61K 31/381 (2013.01); C07D 231/40 (2013.01); C07D 213/75 (2013.01); C07D 401/10 (2013.01); A61K 31/426 (2013.01); C07D 333/20 (2013.01); A61K 31/4192 (2013.01); C07D 417/12 (2013.01); C07D 249/06 (2013.01); A61K 31/4427 (2013.01); A61K 31/415 (2013.01); C07D 257/06 (2013.01); C07D 275/03 (2013.01); C07D 261/14 (2013.01); A61K 31/4155 (2013.01); C07D 471/04 (2013.01); C07D 413/10 (2013.01); C07H 15/26 (2013.01); C07D 491/04 (2013.01); A61K 31/425 (2013.01); C07D 413/04 (2013.01); A61K 31/421 (2013.01); C07D 491/048 (2013.01); C07D 277/46 (2013.01); C07D 263/48 (2013.01); C07D 207/34 (2013.01); C07D 405/12 (2013.01); A61K 31/42 (2013.01); C07D 307/66 (2013.01);
Abstract
Compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or diagnose diseases, disorders, or conditions associated with one or more of the lysophosphatidic acid receptors are provided.